UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Regulator to consider re-classifying choline alfoscerate as functional food
by Kim Yun-mi
2019-11-06 13:54
Merck Korea hurries to close GM part despite union’s protest
by Kim Yun-mi
2019-11-05 15:04
Takeda Korea fires union leader to worsen labor-management dispute
by Kim Yun-mi
2019-11-04 15:03
Hanyang University Medical Center goes research-centered
by Kim Yun-mi
2019-11-01 16:09
Huons’ insomnia cure, 2 other drugs to win insurance benefit
by Kim Yun-mi
2019-10-31 13:22
라인
AbbVie’s new psoriasis drug likely to win nod this year
by Kim Yun-mi
2019-10-30 16:05
Scope of AI-based medical devices expanded for licensing review
by Kim Yun-mi
2019-10-30 16:03
[Special] Yongin Severance Hospital to go digital with innovation
by Kim Yun-mi
2019-10-28 15:45
‘Korean hospitals equipped well to use CAR-T therapy’
by Kim Yun-mi
2019-10-23 13:17
Pfizer’s atopic drug should overcome side effects to challenge Sanofi’s Dupixent
by Kim Yun-mi
2019-10-22 14:17
라인
Merck Korea forcefully shuts down general medicine biz
by Kim Yun-mi
2019-10-15 15:51
Galderma Korea’s key strategy: choice and concentration
by Kim Yun-mi
2019-10-15 13:56
[Special] How are Korean employees coping with big-pharma M&As?
by Kim Yun-mi
2019-10-14 13:45
Sanofi to cover part of Dupixent cost for atopic dermatitis patients
by Kim Yun-mi
2019-10-11 15:13
Doctors call Boehringer Ingelheim’s Jardiance marketing ‘unethical’
by Kim Yun-mi
2019-10-10 16:01
라인
Medtronic Korea denies regulatory negligence over recalled insulin pumps
by Kim Yun-mi
2019-10-08 15:05
Galderma Korea workers feel insecure after separation from Nestle
by Kim Yun-mi
2019-10-07 14:38
CDK4/6 inhibitor+fulvestrant combo nears getting benefit
by Kim Yun-mi
2019-10-02 16:03
‘Merck Korea unilaterally lays off employees’
by Kim Yun-mi
2019-10-01 11:09
Pfizer’s leukemia therapy Besponsa to get insurance benefit
by Kim Yun-mi
2019-09-26 11:26
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top